Home › NDC Lookup › RxCUI directory › RxCUI 809602

Fructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML Oral Solution [Emetrol] — RxCUI 809602

Name: Fructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML Oral Solution [Eme… (RxCUI 809602)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 809602 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI809602

Official nameFructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML Oral Solution [Emetrol]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asEmetrol (sucrose 3.74 GM / phosphoric acid 21.5 MG) per 5 ML Oral Solution; Emetrol 1.87 GM / 1.87 GM / 21.5 MG in 5 mL Oral Solution; Emetrol (dextrose 1.87 GM / fructose 1.87 GM / phosphoric acid 21.5 MG) per 5 ML Oral Solution

FDA products mapped2

Package NDCs mapped4

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dextrose: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Dextrose is essentially glucose — sugar — given directly into a vein. In an emergency, it's used to quickly raise dangerously low blood sugar, which can happen with too much insuli...
Specific formulations — Infant Dextrose (25%) and Dextrose (25% injection) — are FDA-approved to treat low blood sugar in newborns and infants up to 2 years old. That said, prematu...
Is dextrose safe for my baby or newborn?
The most common issues are high blood sugar, vein irritation or clotting at the IV site, low sodium in the blood, and infection. More serious — but less common — reactions include...

📖 Read our full Dextrose guide →

🕸️ Concept Web — How Fructose 374 MG/ML / glucose 374 MG/ML / phospho... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Fructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML Oral Solution [Emetrol] RxCUI 809602 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 4

The active substance itself — no strength, form, or brand attached yet.
- Fructose 4570 IN
- Glucose 4850 IN
- Phosphoric acid 8259 IN
- Fructose / glucose / phosphoric acid 689313 MIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Emetrol 92588 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Fructose / glucose / phosphoric acid Oral Solution 377010 SCDF
- Fructose / glucose / phosphoric acid Oral Liquid Product 1162688 SCDG
- Fructose / glucose / phosphoric acid Oral Product 1162689 SCDG
- Fructose / glucose / phosphoric acid Oral Solution [Emetrol] 364369 SBDF
- Emetrol Oral Liquid Product 1175311 SBDG
- Emetrol Oral Product 1175312 SBDG
- Oral Solution 316968 DF
- Oral Liquid Product 1151137 DFG
- +1 more in this family
Clinical & branded drugs 5

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Fructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML Oral Solution 318146 SCD
- Fructose 374 MG/ML 336945 SCDC
- Glucose 374 MG/ML 336547 SCDC
- Phosphoric acid 4.3 MG/ML 336548 SCDC
- Fructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML [Emetrol] 809601 SBDC

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Fructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML Oral Solution SCD · 318146
Fructose 374 MG/ML SCDC · 336945
Glucose 374 MG/ML SCDC · 336547
Phosphoric acid 4.3 MG/ML SCDC · 336548
Fructose / glucose / phosphoric acid Oral Solution SCDF · 377010
Fructose / glucose / phosphoric acid Oral Liquid Product SCDG · 1162688
Fructose / glucose / phosphoric acid Oral Product SCDG · 1162689

Brand-Name Concepts

Fructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML [Emetrol] SBDC · 809601
Fructose / glucose / phosphoric acid Oral Solution [Emetrol] SBDF · 364369
Emetrol Oral Liquid Product SBDG · 1175311
Emetrol Oral Product SBDG · 1175312
Emetrol BN · 92588

📦 FDA Products & Package NDCs

2 products · 4 package NDCs

4 package NDCs map to RxCUI 809602 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
65197-0201-04	1 BOTTLE in 1 CARTON (65197-201-04) / 118 mL in 1 BOTTLE	Emetrol Cherry	WellSpring Pharmaceutical Corporation	2009-06-24
65197-0201-06	133 mL in 1 BOTTLE (65197-201-06)	Emetrol Cherry	WellSpring Pharmaceutical Corporation	2018-11-01
65197-0201-12	354 mL in 1 BOTTLE (65197-201-12)	Emetrol Cherry	WellSpring Pharmaceutical Corporation	2025-06-15
65197-0202-14	1 BOTTLE in 1 CARTON (65197-202-14) / 118 mL in 1 BOTTLE	Emetrol Children Mixed Berry	WellSpring Pharmaceutical Corporation	2023-06-01

Observed labelers: WellSpring Pharmaceutical Corporation (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.